Opioid Use Disorder Clinical Trials in Seattle, Washington

4 studies are recruiting for opioid use disorder in Seattle, Washington right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder

    VA-BRAVE will determine whether a 28-day long-acting injectable sub-cutaneous formulation of buprenorphine at a target dose of 300 milligrams (mg) is superior in retaining Veterans in opioid treatment and in sustaining opioid abstinence compared to the daily sublingual (under the tongue) buprenorph…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington
    Locations
    25 in total
    Run by
    VA Office of Research and Development

    See if you can join NCT04375033 on ClinicalTrials.gov

  2. A Study of Brenipatide in Participants With Opioid Use Disorder

    The purpose of this study is to see if brenipatide, when compared to placebo, is safe and effective for participants with opioid use disorder, when used with buprenorphine with or without naloxone. The maximum potential duration of study participation for a participant in Part A is approximately 14…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    University of Washington - Harborview Medical Center, Seattle, Washington
    Locations
    59 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07420283 on ClinicalTrials.gov

  3. Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail

    This study evaluates the effectiveness of a health systems strategy (the Systems Analysis and Improvement Approach - SAIA) that packages systems engineering tools (including cascade analysis, flow mapping, and continuous quality improvement) to optimize the management of opioid use disorder (MOUD) …

    Stage
    Not phased
    Ages
    18 to 110
    Site
    University of Washington, Seattle, Washington
    Run by
    University of Washington

    See if you can join NCT06593353 on ClinicalTrials.gov

  4. Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data

    The study is a quasi-experimental investigation of a sub-acute stabilization center (SASC) for people who have had or are at risk for having an opioid overdose and have an encounter with Seattle Fire Department emergency medical services (EMS) in Seattle, WA. Those transported to the SASC are the i…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Downtown Emergency Service Center's Overdose Recovery and Care Access Centers, Seattle, Washington
    Run by
    University of Washington

    See if you can join NCT06768814 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.